Dog owners, veterinarians, and wholesalers are urged to take note of a Class II recall initiated by Dechra for a specific batch of Clavudale 400 mg/100 mg Tablets for Dogs. This recall has been prompted by a stability failure of the product, which has been linked to issues during the manufacturing process.
The primary reason for this recall is attributed to the stability failure of the product. It has been determined that the excessive time that passed between the initial blending stage and the final compression stages during the manufacturing process during rework has led to this problem.
